Absci Corporation

Absci is a biotechnology company that combines artificial intelligence with experimental biology to discover and design therapeutic antibodies. Its approach links computational protein design to laboratory testing, with the goal of creating antibody candidates that can be investigated in drug development. Absci pursues internal therapeutic research and also works with pharmaceutical collaborators on selected programs. The company is distinct from a software-only or contract-service provider because its activities include the development of investigational therapeutic molecules. The official corporate and investor relations websites provide the appropriate sources for updated information about specific research programs, collaborations and securities disclosures.